Revelation Biosciences, Inc. · NASDAQ:REVB

Armistice Capital, LLC reported a 7.80% stake in Revelation Biosciences, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 7.80% stake in Revelation Biosciences, Inc., 323,241 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
7.80%
Shares
323,241
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC7.80%323,241
Steven Boyd7.80%323,241

Source

View original at SEC

Related